|
GS174327: HP:0003198 Myopathy
|
|
GS198194: GO:0034702 ion channel complex
|
|
GS192507: GO:0006812 cation transport
|
|
GS185985: GO:0016818 hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides
|
|
GS205510: GO:0001883 purine nucleoside binding
|
|
GS172666: HP:0011804 Abnormality of muscle physiology
|
|
GS170962: HP:0000159 Abnormality of the lip
|
|
GS188641: GO:0071944 cell periphery
|
|
GS171644: HP:0011842 Abnormality of skeletal morphology
|
|
GS174459: HP:0010174 Broad phalanx of the toes
|
|
GS121514: Paraquat interacting genes (MeSH:D010269) in CTD
|
|
GS175101: HP:0000280 Coarse facial features
|
|
GS177024: HP:0000215 Thick upper lip vermilion
|
|
GS189855: GO:0043168 anion binding
|
|
GS135957: HDL QTL 24 (Hdlq24, Published QTL Chr 6)
|
|
GS173687: HP:0001643 Patent ductus arteriosus
|
|
GS178461: GO:0009987 cellular process
|
|
GS175505: HP:0010057 Abnormality of the phalanges of the hallux
|
|
GS193061: GO:0044444 cytoplasmic part
|
|
GS166257: MP:0005291 abnormal glucose tolerance
|
|
GS172015: HP:0000969 Edema
|
|
GS192624: GO:0043231 intracellular membrane-bounded organelle
|
|
GS175802: HP:0003272 Abnormality of the hip bone
|
|
GS179402: GO:0005216 ion channel activity
|
|
GS186743: GO:0043227 membrane-bounded organelle
|
|
GS204008: GO:0008076 voltage-gated potassium channel complex
|
|
GS175897: HP:0000939 Osteoporosis
|
|
GS183655: GO:0015405 P-P-bond-hydrolysis-driven transmembrane transporter activity
|
|
GS210507: GO:0006950 response to stress
|
|
GS173384: HP:0002750 Delayed skeletal maturation
|
|
GS173392: HP:0003330 Abnormal bone structure
|
|
GS174134: HP:0002012 Abnormality of the abdominal organs
|
|
GS170204: MP:0005595 abnormal vascular smooth muscle physiology
|
|
GS184984: GO:0032553 ribonucleotide binding
|
|
GS170590: MP:0006135 artery stenosis
|
|
GS191193: GO:0009607 response to biotic stimulus
|
|
GS175103: HP:0000288 Abnormality of the philtrum
|
|
GS35266: Striatum Gene expression correlates of Maximum startle response to 80 db in Males BXD
|
|
GS176004: HP:0100656 Thoracoabdominal wall defects
|
|
GS187315: GO:0015459 potassium channel regulator activity
|
|
GS193268: GO:0005575 cellular_component
|
|
GS173786: HP:0003457 EMG abnormality
|
|
GS194039: GO:1901363 heterocyclic compound binding
|
|
GS175506: HP:0010054 Abnormality of the first metatarsal
|
|
GS183645: GO:0017076 purine nucleotide binding
|
|
GS170736: MP:0000189 hypoglycemia
|
|
GS192550: GO:0008281 sulfonylurea receptor activity
|
|
GS171596: HP:0000164 Abnormality of the teeth
|
|
GS175507: HP:0010055 Broad hallux
|
|
GS176151: HP:0000256 Macrocephaly
|
|
GS195083: GO:0007267 cell-cell signaling
|
|
GS176638: HP:0011603 Congenital malformation of the great arteries
|
|
GS176385: HP:0001249 Intellectual disability
|
|
GS171902: HP:0010987 Abnormality of cellular immune system
|
|
GS172363: HP:0004324 Increased body weight
|
|
GS175893: HP:0000932 Abnormality of the posterior cranial fossa
|
|
GS176817: HP:0011446 Abnormality of higher mental function
|
|
GS163852: MP:0001544 abnormal cardiovascular system physiology
|
|
GS197443: GO:0032549 ribonucleoside binding
|
|
GS175249: HP:0008822 Hypoplastic ischiopubic rami
|
|
GS172170: HP:0003196 Short nose
|
|
GS174494: HP:0002564 Malformation of the heart and great vessels
|
|
GS176107: HP:0000929 Abnormality of the skull
|
|
GS190713: GO:0016021 integral to membrane
|
|
GS172032: HP:0000366 Abnormality of the nose
|
|
GS181423: GO:0022891 substrate-specific transmembrane transporter activity
|
|
GS170783: HP:0010974 Abnormality of myeloid leukocytes
|
|
GS173372: HP:0011297 Abnormality of the digits
|
|
GS201730: GO:0002252 immune effector process
|
|
GS136587: renal cystic disease severity (Rencd, Published QTL Chr 6)
|
|
GS126646: Carbon Tetrachloride interacting genes (MeSH:D002251) in CTD
|
|
GS176098: HP:0000927 Abnormality of skeletal maturation
|
|
GS172789: HP:0001537 Umbilical hernia
|
|
GS196343: GO:0036094 small molecule binding
|
|
GS170964: HP:0000152 Abnormality of head and neck
|
|
GS173751: HP:0000998 Hypertrichosis
|
|
GS196857: GO:0034220 ion transmembrane transport
|
|
GS191106: GO:0044464 cell part
|
|
GS172054: HP:0001507 Growth abnormality
|
|
GS173290: HP:0011354 Generalized abnormality of skin
|
|
GS184917: GO:0002252 immune effector process
|
|
GS210137: GO:0016462 pyrophosphatase activity
|
|
GS177404: GO:0005737 cytoplasm
|
|
GS201251: GO:0044424 intracellular part
|
|
GS195770: GO:0015672 monovalent inorganic cation transport
|
|
GS172031: HP:0000364 Hearing abnormality
|
|
GS172151: HP:0002673 Coxa valga
|
|
GS192508: GO:0006811 ion transport
|
|
GS176840: HP:0001911 Abnormality of granulocytes
|
|
GS190368: GO:0042623 ATPase activity, coupled
|
|
GS183543: GO:0051179 localization
|
|
GS178909: GO:0017111 nucleoside-triphosphatase activity
|
|
GS172525: HP:0001698 Pericardial effusion
|
|
GS135469: blood pressure QTL 5 (Bpq5, Published QTL Chr 6)
|
|
GS175907: HP:0004349 Reduced bone mineral density
|
|
GS166660: MP:0001731 abnormal postnatal growth
|
|
GS163843: MP:0000231 hypertension
|
|
GS176242: HP:0004207 Abnormality of the 5th finger
|
|
GS205500: GO:0071944 cell periphery
|
|
GS166979: MP:0004130 abnormal muscle cell glucose uptake
|
|
GS209491: GO:0008281 sulfonylurea receptor activity
|
|
GS209108: GO:0000166 nucleotide binding
|
|
GS174187: HP:0001595 Abnormality of the hair
|
|
GS136146: lithogenic gene 6 (Lith6, Published QTL Chr 6)
|
|
GS163824: MP:0001259 abnormal body weight
|
|
GS203494: GO:0051704 multi-organism process
|
|
GS175909: HP:0004348 Abnormality of bone mineral density
|
|
GS174245: HP:0001844 Abnormality of the hallux
|
|
GS188652: GO:0001882 nucleoside binding
|
|
GS204106: GO:0060089 molecular transducer activity
|
|
GS192506: GO:0006813 potassium ion transport
|
|
GS191171: GO:0030315 T-tubule
|
|
GS135881: femur geometry 5 (Fmgty5, Published QTL Chr 6)
|
|
GS136206: lung tumor shape-determining 8 (Ltsd8, Published QTL Chr 6)
|
|
GS136960: weight adult 2 (Wta2, Published QTL Chr 6)
|
|
GS171999: HP:0001760 Abnormality of the foot
|
|
GS201799: GO:0032550 purine ribonucleoside binding
|
|
GS201800: GO:0032553 ribonucleotide binding
|
|
GS135505: bulb size 2 (Bulb2, Published QTL Chr 6)
|
|
GS192671: GO:0055085 transmembrane transport
|
|
GS188651: GO:0001883 purine nucleoside binding
|
|
GS170733: MP:0000188 abnormal circulating glucose level
|
|
GS172360: HP:0004323 Abnormality of body weight
|
|
GS173449: HP:0002683 Abnormality of the calvaria
|
|
GS174214: HP:0009466 Radial deviation of finger
|
|
GS192203: GO:0015399 primary active transmembrane transporter activity
|
|
GS197892: GO:0043228 non-membrane-bounded organelle
|
|
GS174998: HP:0007665 Curly eyelashes
|
|
GS179401: GO:0005215 transporter activity
|
|
GS172916: HP:0003312 Abnormal form of the vertebral bodies
|
|
GS189443: GO:0044449 contractile fiber part
|
|
GS196808: GO:0032501 multicellular organismal process
|
|
GS171708: HP:0000359 Abnormality of the inner ear
|
|
GS186744: GO:0043226 organelle
|
|
GS198782: GO:0044459 plasma membrane part
|
|
GS206312: GO:0044449 contractile fiber part
|
|
GS202715: GO:0035637 multicellular organismal signaling
|
|
GS182835: GO:0005622 intracellular
|
|
GS36775: Hippocampus Gene expression correlates of Zero Maze - Percentage open time in Males BXD
|
|
GS213074: Genes with suggestive difference in (B6PF1) vs (PB6F1 + B6 + PWD) comparison
|
|
GS173740: HP:0009485 Radial deviation of the hand or of fingers of the hand
|
|
GS180228: GO:0005887 integral to plasma membrane
|
|
GS176844: HP:0000429 Abnormality of the nasal alae
|
|
GS171253: HP:0002817 Abnormality of the upper limb
|
|
GS177749: GO:0071804 cellular potassium ion transport
|
|
GS194133: GO:0005737 cytoplasm
|
|
GS176231: HP:0010938 Abnormality of the external nose
|
|
GS169075: MP:0002078 abnormal glucose homeostasis
|
|
GS194111: GO:0097159 organic cyclic compound binding
|
|
GS189860: GO:0043167 ion binding
|
|
GS179009: GO:0015672 monovalent inorganic cation transport
|
|
GS171645: HP:0011843 Abnormality of skeletal physiology
|
|
GS174217: HP:0005105 Abnormal nasal morphology
|
|
GS191129: GO:0016787 hydrolase activity
|
|
GS194001: GO:0010107 potassium ion import
|
|
GS184448: GO:0044425 membrane part
|
|
GS136630: small effect CIA locus 3 (Secia3, Published QTL Chr 6)
|
|
GS199199: GO:0031226 intrinsic to plasma membrane
|
|
GS171752: HP:0001713 Abnormality of cardiac ventricle
|
|
GS200341: GO:0051179 localization
|
|
GS206742: GO:0043167 ion binding
|
|
GS174486: HP:0000527 Long eyelashes
|
|
GS165386: MP:0001262 decreased body weight
|
|
GS202828: GO:0016817 hydrolase activity, acting on acid anhydrides
|
|
GS163929: MP:0002891 increased insulin sensitivity
|
|
GS182594: GO:0019905 syntaxin binding
|
|
GS171600: HP:0000168 Abnormality of the gingiva
|
|
GS204130: GO:0009615 response to virus
|
|
GS208574: GO:0044325 ion channel binding
|
|
GS192646: GO:0022804 active transmembrane transporter activity
|
|
GS195082: GO:0007268 synaptic transmission
|
|
GS171924: HP:0100578 Lipoatrophy
|
|
GS126830: Potassium interacting genes (MeSH:D011188) in CTD
|
|
GS170890: HP:0006483 Abnormal number of teeth
|
|
GS172906: HP:0003319 Abnormality of the cervical spine
|
|
GS165208: MP:0002842 increased systemic arterial blood pressure
|
|
GS171815: HP:0001574 Abnormality of the integument
|
|
GS174719: HP:0000774 Narrow chest
|
|
GS181473: GO:0005488 binding
|
|
GS174851: HP:0000944 Abnormality of the metaphyses
|
|
GS175526: HP:0000005 Mode of inheritance
|
|
GS174014: HP:0010109 Small hallux
|
|
GS192512: GO:0003824 catalytic activity
|
|
GS180644: GO:0032549 ribonucleoside binding
|
|
GS207616: GO:0016020 membrane
|
|
GS213077: Genes with suggestive difference in (PWD) vs (PB6F1 + B6PF1 + B6) comparison
|
|
GS171647: HP:0011844 Abnormal appendicular skeleton morphology
|
|
GS171862: HP:0008362 Aplasia/Hypoplasia of the hallux
|
|
GS175979: HP:0009115 Aplasia/Hypoplasia involving the skeleton
|
|
GS176775: HP:0001004 Lymphedema
|
|
GS182559: GO:0005261 cation channel activity
|
|
GS186645: GO:0051704 multi-organism process
|
|
GS174847: HP:0000940 Abnormal diaphysis morphology
|
|
GS180229: GO:0005886 plasma membrane
|
|
GS199048: GO:0016820 hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances
|
|
GS135769: experimental autoimmune myocarditis 2 (Eamcd2, Published QTL Chr 6)
|
|
GS172415: HP:0002240 Hepatomegaly
|
|
GS163601: MP:0002089 abnormal postnatal growth/weight/body size
|
|
GS184146: GO:0000149 SNARE binding
|
|
GS166661: MP:0000250 abnormal vasoconstriction
|
|
GS191726: GO:0008282 ATP-sensitive potassium channel complex
|
|
GS192680: GO:0038023 signaling receptor activity
|
|
GS35276: Striatum Gene expression correlates of Maximum startle response to 85 db in Males BXD
|
|
GS135447: bone length and organs 3 (Bod3, Published QTL Chr 6)
|
|
GS177409: GO:0005739 mitochondrion
|
|
GS191639: GO:0044325 ion channel binding
|
|
GS172433: HP:0002644 Abnormality of pelvic girdle bone morphology
|
|
GS173535: HP:0001874 Abnormality of neutrophils
|
|
GS176099: HP:0000926 Platyspondyly
|
|
GS165527: MP:0005378 growth/size phenotype
|
|
GS191982: GO:0030016 myofibril
|
|
GS175529: HP:0000001 All
|
|
GS124711: Genistein interacting genes (MeSH:D019833) in CTD
|
|
GS175459: HP:0009484 Deviation of the hand or of fingers of the hand
|
|
GS175527: HP:0000006 Autosomal dominant inheritance
|
|
GS136655: skeletal muscle weight 14 (Skmw14, Published QTL Chr 6)
|
|
GS181685: GO:0042383 sarcolemma
|
|
GS184447: GO:0044424 intracellular part
|
|
GS206737: GO:0043168 anion binding
|
|
GS176189: HP:0009103 Aplasia/Hypoplasia involving the pelvis
|
|
GS178812: GO:0015267 channel activity
|
|
GS191983: GO:0030017 sarcomere
|
|
GS209863: GO:0050896 response to stimulus
|
|
GS172590: HP:0001837 Broad toe
|
|
GS190365: GO:0042626 ATPase activity, coupled to transmembrane movement of substances
|
|
GS136124: lipoprotein QTL 1 (Lipq1, Published QTL Chr 6)
|
|
GS187881: GO:0004888 transmembrane signaling receptor activity
|
|
GS173872: HP:0011368 Epidermal thickening
|
|
GS186740: GO:0043229 intracellular organelle
|
|
GS173367: HP:0005257 Thoracic hypoplasia
|
|
GS171105: HP:0006494 Aplasia/Hypoplasia involving bones of the feet
|
|
GS171609: HP:0011339 Abnormality of upper lip vermillion
|
|
GS193288: GO:0015079 potassium ion transmembrane transporter activity
|
|
GS172514: HP:0001697 Abnormality of the pericardium
|
|
GS171758: HP:0001714 Ventricular hypertrophy
|
|
GS179671: GO:0030001 metal ion transport
|
|
GS171448: HP:0000606 Abnormality of the periorbital region
|
|
GS188954: GO:0022838 substrate-specific channel activity
|
|
GS208012: GO:0044464 cell part
|
|
GS181424: GO:0022890 inorganic cation transmembrane transporter activity
|
|
GS87380: Table S1: Additional data file 1 is a table listing the results of two-way ANOVA (FDR < 1%). (Whole Table) [DRG]
|
|
GS201252: GO:0044425 membrane part
|
|
GS210212: GO:0005575 cellular_component
|
|
GS171235: HP:0010184 Abnormality of the proximal phalanges of the toes
|
|
GS173361: HP:0004540 Congenital, generalized hypertrichosis
|
|
GS178899: GO:0016247 channel regulator activity
|
|
GS136232: mandible length 6 (Manln6, Published QTL Chr 6)
|
|
GS180083: GO:0034220 ion transmembrane transport
|
|
GS209451: GO:0006811 ion transport
|
|
GS865: Sey_Pax6_Age_Reduced_Linear_Incr
|
|
GS175164: HP:0011927 Short digit
|
|
GS169557: MP:0008489 slow postnatal weight gain
|
|
GS170980: HP:0011362 Abnormal hair quantity
|
|
GS181532: GO:0046873 metal ion transmembrane transporter activity
|
|
GS178478: GO:0015077 monovalent inorganic cation transmembrane transporter activity
|
|
GS179580: GO:0036094 small molecule binding
|
|
GS209137: GO:0015399 primary active transmembrane transporter activity
|
|
GS175471: HP:0001172 Abnormality of the thumb
|
|
GS201792: GO:0032559 adenyl ribonucleotide binding
|
|
GS172552: HP:0004634 Cuboid-shaped vertebral bodies
|
|
GS192789: GO:0008324 cation transmembrane transporter activity
|
|
GS176101: HP:0000924 Abnormality of the skeletal system
|
|
GS196432: GO:0030001 metal ion transport
|
|
GS172154: HP:0002679 Abnormality of the sella turcica
|
|
GS173691: HP:0001647 Bicuspid aortic valve
|
|
GS123718: Ethinyl Estradiol interacting genes (MeSH:D004997) in CTD
|
|
GS174915: HP:0003016 Metaphyseal widening
|
|
GS176759: HP:0000982 Palmoplantar keratoderma
|
|
GS173686: HP:0001640 Cardiomegaly
|
|
GS174500: HP:0000707 Abnormality of the nervous system
|
|
GS208384: GO:0016887 ATPase activity
|
|
GS171998: HP:0001939 Abnormality of metabolism/homeostasis
|
|
GS172300: HP:0001991 Aplasia/Hypoplasia of the toes
|
|
GS203491: GO:0051707 response to other organism
|
|
GS174721: HP:0000772 Abnormality of the ribs
|
|
GS189317: GO:0043292 contractile fiber
|
|
GS167020: MP:0003956 abnormal body size
|
|
GS198193: GO:0034705 potassium channel complex
|
|
GS164263: MP:0002083 premature death
|
|
GS165616: MP:0002127 abnormal cardiovascular system morphology
|
|
GS165789: MP:0005369 muscle phenotype
|
|
GS174071: HP:0009125 Lipodystrophy
|
|
GS191457: GO:0016887 ATPase activity
|
|
GS181425: GO:0022892 substrate-specific transporter activity
|
|
GS182834: GO:0005623 cell
|
|
GS177051: HP:0001155 Abnormality of the hand
|
|
GS199201: GO:0031224 intrinsic to membrane
|
|
GS173083: HP:0000492 Abnormality of the eyelid
|
|
GS173630: HP:0002690 Large sella turcica
|
|
GS205511: GO:0001882 nucleoside binding
|
|
GS194489: GO:0071805 potassium ion transmembrane transport
|
|
GS176745: HP:0010866 Abdominal wall defect
|
|
GS197016: GO:0032991 macromolecular complex
|
|
GS173617: HP:0011220 Prominent forehead
|
|
GS174914: HP:0003011 Abnormality of the musculature
|
|
GS182474: GO:0043232 intracellular non-membrane-bounded organelle
|
|
GS199635: GO:0005622 intracellular
|
|
GS171461: HP:0011121 Abnormality of skin morphology
|
|
GS135367: B.burgdorferi-associated arthritis 5 (Bbaa5, Published QTL Chr 6)
|
|
GS172569: HP:0000343 Long philtrum
|
|
GS174814: HP:0001639 Hypertrophic cardiomyopathy
|
|
GS204171: GO:0015459 potassium channel regulator activity
|
|
GS177274: GO:0010107 potassium ion import
|
|
GS181406: GO:0034703 cation channel complex
|
|
GS136075: insulin QTL 8 (Insq8, Published QTL Chr 6)
|
|
GS171397: HP:0000177 Abnormality of upper lip
|
|
GS166675: MP:0005292 improved glucose tolerance
|
|
GS195655: GO:0016247 channel regulator activity
|
|
GS171228: HP:0002823 Abnormality of the femur
|
|
GS136425: pulmonary adenoma susceptibility 1 (Pas1, Published QTL Chr 6)
|
|
GS174075: HP:0009121 Abnormal axial skeleton morphology
|
|
GS196941: GO:0008150 biological_process
|
|
GS169706: MP:0006144 increased systemic arterial systolic blood pressure
|
|
GS170368: MP:0000249 abnormal blood vessel physiology
|
|
GS176166: HP:0001256 Intellectual disability, mild
|
|
GS209449: GO:0006813 potassium ion transport
|
|
GS199634: GO:0005623 cell
|
|
GS208922: GO:0030017 sarcomere
|
|
GS164136: MP:0000001 mammalian phenotype
|
|
GS197009: GO:0005886 plasma membrane
|
|
GS176907: HP:0009804 Reduced number of teeth
|
|
GS201256: GO:0044422 organelle part
|
|
GS204007: GO:0044700 single organism signaling
|
|
GS176233: HP:0004209 Clinodactyly of the 5th finger
|
|
GS201431: GO:0005515 protein binding
|
|
GS208107: GO:0009607 response to biotic stimulus
|
|
GS173743: HP:0001999 Abnormal facial shape
|
|
GS176613: HP:0000271 Abnormality of the face
|
|
GS175928: HP:0000240 Abnormality of skull size
|
|
GS176973: HP:0001072 Thickened skin
|
|
GS203649: GO:0030554 adenyl nucleotide binding
|
|
GS176154: HP:0010068 Broad first metatarsal
|
|
GS187247: GO:0060089 molecular transducer activity
|
|
GS126276: pirinixic acid interacting genes (MeSH:C006253) in CTD
|
|
GS171207: HP:0000098 Tall stature
|
|
GS190027: GO:0006952 defense response
|
|
GS173234: HP:0004975 Erlenmeyer flask deformity of the femurs
|
|
GS174070: HP:0009124 Abnormality of adipose tissue
|
|
GS209613: GO:0055085 transmembrane transport
|
|
GS175016: HP:0001626 Abnormality of the cardiovascular system
|
|
GS175990: HP:0000463 Anteverted nares
|
|
GS210132: GO:0043492 ATPase activity, coupled to movement of substances
|
|
GS135410: body growth late QTL 5 (Bglq5, Published QTL Chr 6)
|
|
GS199267: GO:0043234 protein complex
|
|
GS135380: bone density traits 3 (Bdt3, Published QTL Chr 6)
|
|
GS171753: HP:0001712 Left ventricular hypertrophy
|
|
GS169915: MP:0005560 decreased circulating glucose level
|
|
GS171274: HP:0100543 Cognitive impairment
|
|
GS184485: GO:0008144 drug binding
|
|
GS35256: Striatum Gene expression correlates of Maximum startle response to 70 db in Males BXD
|
|
GS175805: HP:0003271 Visceromegaly
|
|
GS209586: GO:0022804 active transmembrane transporter activity
|
|
GS170198: MP:0001614 abnormal blood vessel morphology
|
|
GS175902: HP:0003468 Abnormality of the vertebrae
|
|
GS175981: HP:0000163 Abnormality of the oral cavity
|
|
GS184976: GO:0032559 adenyl ribonucleotide binding
|
|
GS199272: GO:0043232 intracellular non-membrane-bounded organelle
|
|
GS171409: HP:0011306 Aplasia of the toes
|
|
GS207263: GO:0042623 ATPase activity, coupled
|
|
GS209452: GO:0006810 transport
|
|
GS176100: HP:0000925 Abnormality of the vertebral column
|
|
GS204608: GO:0019226 transmission of nerve impulse
|
|
GS171848: HP:0000598 Abnormality of the ear
|
|
GS173343: HP:0001548 Overgrowth
|
|
GS175015: HP:0001627 Abnormality of the heart
|
|
GS169711: MP:0006143 increased systemic arterial diastolic blood pressure
|
|
GS175096: HP:0000286 Epicanthus
|
|
GS204021: GO:0044707 single-multicellular organism process
|
|
GS135532: cadmium-induced forelimb autopod reduction defect (Cadfar, Published QTL Chr 6)
|
|
GS184629: GO:0005515 protein binding
|
|
GS175149: HP:0009179 Deviation of the 5th finger
|
|
GS164586: MP:0010508 abnormal heart electrocardiography waveform feature
|
|
GS177843: GO:0002376 immune system process
|
|
GS175113: HP:0000574 Thick eyebrow
|
|
GS127240: Acetaminophen interacting genes (MeSH:D000082) in CTD
|
|
GS194459: GO:0051234 establishment of localization
|
|
GS185920: GO:0004872 receptor activity
|
|
GS185881: GO:0035639 purine ribonucleoside triphosphate binding
|
|
GS174462: HP:0002648 Abnormality of calvarial morphology
|
|
GS185991: GO:0016817 hydrolase activity, acting on acid anhydrides
|
|
GS202760: GO:0004871 signal transducer activity
|
|
GS165397: MP:0001265 decreased body size
|
|
GS170600: MP:0005620 abnormal muscle contractility
|
|
GS176246: HP:0001783 Broad metatarsal
|
|
GS176185: HP:0100790 Hernia
|
|
GS135522: body weight QTL 10 (Bwtq10, Published QTL Chr 6)
|
|
GS171789: HP:0001392 Abnormality of the liver
|
|
GS176251: HP:0009104 Aplasia/Hypoplasia of the pubic bone
|
|
GS202899: GO:0050877 neurological system process
|
|
GS135946: HDL QTL 12 (Hdlq12, Published QTL Chr 6)
|
|
GS173087: HP:0000499 Abnormality of the eyelashes
|
|
GS175509: HP:0010059 Broad phalanges of the hallux
|
|
GS186078: GO:0022803 passive transmembrane transporter activity
|
|
GS172030: HP:0000365 Hearing impairment
|
|
GS202716: GO:0035639 purine ribonucleoside triphosphate binding
|
|
GS202759: GO:0004872 receptor activity
|
|
GS172021: HP:0001367 Abnormal joint morphology
|
|
GS173901: HP:0002007 Frontal bossing
|
|
GS170965: HP:0000153 Abnormality of the mouth
|
|
GS171204: HP:0011314 Abnormality of long bone morphology
|
|
GS186642: GO:0051707 response to other organism
|
|
GS203594: GO:0043226 organelle
|
|
GS195665: GO:0017111 nucleoside-triphosphatase activity
|
|
GS171018: HP:0003173 Hypoplastic pubic bones
|
|
GS172667: HP:0011805 Abnormality of muscle morphology
|
|
GS136662: skin tumor susceptibility 12 (Skts12, Published QTL Chr 6)
|
|
GS172604: HP:0005445 Widened posterior fossa
|
|
GS174088: HP:0003366 Abnormality of the femoral neck and head region
|
|
GS200446: GO:0017076 purine nucleotide binding
|
|
GS210002: GO:0044444 cytoplasmic part
|
|
GS171168: HP:0000234 Abnormality of the head
|
|
GS171908: HP:0004298 Abnormality of the abdominal wall
|
|
GS136656: skeletal muscle weight 15 (Skmw15, Published QTL Chr 6)
|
|
GS175530: HP:0000002 Abnormality of body height
|
|
GS194586: GO:0002376 immune system process
|
|
GS209622: GO:0038023 signaling receptor activity
|
|
GS184983: GO:0032550 purine ribonucleoside binding
|
|
GS165537: MP:0005376 homeostasis/metabolism phenotype
|
|
GS167984: MP:0003137 abnormal impulse conducting system conduction
|
|
GS167347: MP:0003897 abnormal ST segment
|
|
GS181988: GO:0044459 plasma membrane part
|
|
GS174331: HP:0002715 Abnormality of the immune system
|
|
GS209960: GO:0003008 system process
|
|
GS192174: GO:0000166 nucleotide binding
|
|
GS181102: GO:0043228 non-membrane-bounded organelle
|
|
GS164742: MP:0001732 postnatal growth retardation
|
|
GS171102: HP:0006493 Aplasia/Hypoplasia involving bones of the lower limbs
|
|
GS136871: T cell ratio modifier QTL 1 (Trmq1, Published QTL Chr 6)
|
|
GS206183: GO:0043292 contractile fiber
|
|
GS171019: HP:0003172 Abnormality of the pubic bones
|
|
GS182404: GO:0031224 intrinsic to membrane
|
|
GS127166: bisphenol A interacting genes (MeSH:C006780) in CTD
|
|
GS174131: HP:0002011 Abnormality of the central nervous system
|
|
GS173465: HP:0001654 Abnormality of the heart valves
|
|
GS194087: GO:0003674 molecular_function
|
|
GS168750: MP:0002191 abnormal artery morphology
|
|
GS171424: HP:0002814 Abnormality of the lower limb
|
|
GS185176: GO:0005267 potassium channel activity
|
|
GS175304: HP:0000290 Abnormality of the forehead
|
|
GS136278: modifier of ocular retardation 1 (Modor1, Published QTL Chr 6)
|
|
GS172588: HP:0001831 Short toe
|
|
GS177356: GO:0003674 molecular_function
|
|
GS207615: GO:0016021 integral to membrane
|
|
GS203590: GO:0043229 intracellular organelle
|
|
GS208663: GO:0008282 ATP-sensitive potassium channel complex
|
|
GS171390: HP:0000178 Abnormality of lower lip
|
|
GS177309: GO:1901363 heterocyclic compound binding
|
|
GS182402: GO:0031226 intrinsic to plasma membrane
|
|
GS175119: HP:0001881 Abnormality of leukocytes
|
|
GS136564: radiation pulmonary fibrosis 3 (Radpf3, Published QTL Chr 6)
|
|
GS207260: GO:0042626 ATPase activity, coupled to transmembrane movement of substances
|
|
GS174813: HP:0001638 Cardiomyopathy
|
|
GS176145: HP:0001780 Abnormality of toe
|
|
GS171832: HP:0000118 Phenotypic abnormality
|
|
GS178474: GO:0015075 ion transmembrane transporter activity
|
|
GS203886: GO:1901265 nucleoside phosphate binding
|
|
GS197610: GO:0022857 transmembrane transporter activity
|
|
GS176082: HP:0003175 Hypoplastic ischia
|
|
GS204740: GO:0004888 transmembrane signaling receptor activity
|
|
GS177382: GO:0097159 organic cyclic compound binding
|
|
GS171251: HP:0003549 Abnormality of connective tissue
|
|
GS175074: HP:0001156 Brachydactyly syndrome
|
|
GS123803: Glyburide interacting genes (MeSH:D005905) in CTD
|
|
GS192509: GO:0006810 transport
|
|
GS198195: GO:0034703 cation channel complex
|
|
GS176692: HP:0009815 Aplasia/Hypoplasia of the extremities
|
|
GS176727: HP:0003043 Abnormality of the shoulder
|
|
GS206909: GO:0006952 defense response
|
|
GS184978: GO:0032555 purine ribonucleotide binding
|
|
GS84189: ethanol conditioned taste aversion (Published QTL, Chr 6)
|
|
GS172040: HP:0000962 Hyperkeratosis
|
|
GS172585: HP:0001832 Abnormality of the metatarsal bones
|
|
GS175268: HP:0001167 Abnormality of finger
|
|
GS197008: GO:0005887 integral to plasma membrane
|
|
GS171144: HP:0005280 Depressed nasal bridge
|
|
GS190714: GO:0016020 membrane
|
|
GS208921: GO:0030016 myofibril
|
|
GS174251: HP:0010161 Abnormality of the phalanges of the toes
|
|
GS209450: GO:0006812 cation transport
|
|
GS171627: HP:0000470 Short neck
|
|
GS171139: HP:0005288 Abnormality of the nares
|
|
GS175098: HP:0000284 Abnormality of the ocular region
|
|
GS173787: HP:0002813 Abnormality of limb bone morphology
|
|
GS188322: GO:0005524 ATP binding
|
|
GS195214: GO:0009987 cellular process
|
|
GS163934: MP:0001764 abnormal homeostasis
|
|
GS184452: GO:0044422 organelle part
|
|
GS193193: GO:0016462 pyrophosphatase activity
|
|
GS171384: HP:0001551 Abnormality of the umbilicus
|
|
GS172681: HP:0003300 Ovoid vertebral bodies
|
|
GS165525: MP:0010768 mortality/aging
|
|
GS193052: GO:0051607 defense response to virus
|
|
GS201794: GO:0032555 purine ribonucleotide binding
|
|
GS196168: GO:0005215 transporter activity
|
|
GS171391: HP:0000179 Thick lower lip vermilion
|
|
GS177750: GO:0071805 potassium ion transmembrane transport
|
|
GS171148: HP:0011218 Abnormal shape of the frontal region
|
|
GS180817: GO:0022857 transmembrane transporter activity
|
|
GS174917: HP:0000765 Abnormality of the thorax
|
|
GS174335: HP:0001871 Abnormality of blood and blood-forming tissues
|
|
GS175714: HP:0011389 Functional abnormality of the inner ear
|
|
GS187023: GO:1901265 nucleoside phosphate binding
|
|
GS86906: Table S1: Additional data file 1 is a table listing the results of two-way ANOVA (FDR < 1%). Lists of probe sets and gene names altered by strain (3457). [DRG]
provisional
|
|
GS164290: MP:0005412 vascular stenosis
|
|
GS174549: HP:0005129 Congenital hypertrophy of left ventricle
|
|
GS198263: GO:0005488 binding
|
|
GS176040: HP:0011032 Abnormality of fluid regulation
|
|
GS206355: GO:0023052 signaling
|
|
GS192918: GO:0050896 response to stimulus
|
|
GS35246: Striatum Gene expression correlates of Maximum startle to 120 db in Males BXD
|
|
GS172547: HP:0001520 Large for gestational age
|
|
GS84190: METH responses for body temperature (Published QTL, Chr 6)
|
|
GS174236: HP:0000534 Abnormality of the eyebrow
|
|
GS125669: Phenylephrine interacting genes (MeSH:D010656) in CTD
|
|
GS176955: HP:0000431 Wide nasal bridge
|
|
GS181405: GO:0034702 ion channel complex
|
|
GS186798: GO:0030554 adenyl nucleotide binding
|
|
GS165524: MP:0010769 abnormal survival
|
|
GS170971: HP:0000407 Sensorineural hearing impairment
|
|
GS35779: Neocortex Gene expression correlates of CPP - Time (s) in drug-paired compartment a in Males BXD
|
|
GS208037: GO:0016787 hydrolase activity
|
|
GS200456: GO:0015405 P-P-bond-hydrolysis-driven transmembrane transporter activity
|
|
GS187147: GO:0008076 voltage-gated potassium channel complex
|
|
GS182249: GO:0016820 hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances
|
|
GS195977: GO:0007154 cell communication
|
|
GS174089: HP:0003367 Abnormality of the femoral neck
|
|
GS194488: GO:0071804 cellular potassium ion transport
|
|
GS171413: HP:0004097 Deviation of finger
|
|
GS171754: HP:0001711 Abnormality of the left ventricle
|
|
GS182469: GO:0043234 protein complex
|
|
GS173692: HP:0001646 Abnormality of the aortic valve
|
|
GS163842: MP:0000230 abnormal systemic arterial blood pressure
|
|
GS174453: HP:0001438 Abnormality of the abdomen
|
|
GS180164: GO:0008150 biological_process
|
|
GS174812: HP:0001637 Abnormality of the myocardium
|
|
GS181404: GO:0034705 potassium channel complex
|
|
GS168995: MP:0009642 abnormal blood homeostasis
|
|
GS205179: GO:0005524 ATP binding
|
|
GS187272: GO:0009615 response to virus
|
|
GS169829: MP:0005385 cardiovascular system phenotype
|
|
GS180236: GO:0032991 macromolecular complex
|
|
GS185921: GO:0004871 signal transducer activity
|
|
GS171020: HP:0003174 Abnormality of the ischium
|
|
GS177721: GO:0051234 establishment of localization
|
|
GS124346: dicyclanil interacting genes (MeSH:C121718) in CTD
|
|
GS175994: HP:0000464 Abnormality of the neck
|
|
GS171258: HP:0011138 Abnormality of skin adnexa
|
|
GS193188: GO:0043492 ATPase activity, coupled to movement of substances
|
|
GS209455: GO:0003824 catalytic activity
|
|
GS122305: resveratrol interacting genes (MeSH:C059514) in CTD
|
|
GS173167: HP:0100491 Abnormality of the joints of the lower limbs
|
|
GS176924: HP:0000212 Gingival overgrowth
|
|
GS176885: HP:0002693 Abnormality of the skull base
|
|
GS209993: GO:0051607 defense response to virus
|
|
GS193563: GO:0006950 response to stress
|
|
GS202822: GO:0016818 hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides
|
|
GS171907: HP:0004299 Hernia of the abdominal wall
|
|
GS176836: HP:0000422 Abnormality of the nasal bridge
|
|
GS174646: HP:0000951 Abnormality of the skin
|
|
GS166120: MP:0002106 abnormal muscle physiology
|
|
GS201949: GO:0044699 single-organism process
|